- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03892980
Robotic-Assisted da Vinci Xi Prophylactic Nipple-Sparing Mastectomy
A Prospective, Multicenter Investigation of the da Vinci® Surgical Systems in Nipple Sparing Mastectomy (NSM) Procedures
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Surgical management for breast cancer and risk-reducing techniques have evolved from radical mastectomy to other techniques such as nipple and skin sparing procedures. Nipple-sparing mastectomy (NSM) with reconstruction technology offers the opportunity to preserve the shape of both the breast and the nipple-areola complex.
This study will evaluate the safety and effectiveness of the da Vinci Surgical Systems in NSM procedures.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tish Mikoczi
- Phone Number: 760-274-5811
- Email: NSM-Xi@intusurg.com
Study Locations
-
-
Florida
-
Jacksonville, Florida, United States, 32224
- Recruiting
- Mayo Clinic Florida
-
Contact:
- Amanda Arnold
-
Principal Investigator:
- James Jakub, MD
-
-
Illinois
-
Evanston, Illinois, United States, 60201
- Recruiting
- NorthShore University Health System
-
Contact:
- Sarah Rabbitt, RN
-
Principal Investigator:
- Katherine Kopkash, MD
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Mayo Clinic
-
Contact:
- Jennifer Krogman
-
Principal Investigator:
- Mara Piltin, DO
-
-
New York
-
New Hyde Park, New York, United States, 11040
- Recruiting
- Northwell Health
-
Contact:
- Kirendra Pasram
-
Principal Investigator:
- Alan Kadison, MD
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19107
- Recruiting
- University of Pennsylvania
-
Principal Investigator:
- Ari Brooks, MD
-
Contact:
- Ari Brooks, MD
-
-
Texas
-
Houston, Texas, United States, 77030
- Recruiting
- MD Anderson Cancer Center
-
Contact:
- Rosa Hwang, MD
-
Principal Investigator:
- Rosa Hwang, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female between ages 18-80.
- BMI ≤ 29.
- Candidate for an NSM procedure.
- At increased risk for breast cancer and is seeking prophylactic NSM surgery or subject has breast cancer in one breast and is seeking prophylactic NSM on contralateral side.
- Breast ptosis ≤ Grade 2.
- Cup size ≤ C.
- No presence of occult cancer on the side for which she is seeking prophylactic NSM surgery as confirmed by physical exam and by preoperative imaging per institution's guidelines.
Exclusion Criteria:
- Current or prior history of ipsilateral in-situ or invasive breast carcinoma on the breast for which she is seeking prophylactic NSM surgery.
- Previous breast surgery of the ipsilateral breast (excluding needle or core biopsies and excisional biopsies performed more than 1 year prior).
- Current history of smoking or has smoked within 1 year of screening.
- Skin conditions
- Uncontrolled diabetes mellitus.
- Previous chemotherapy or radiation
- High risk for anesthesia or significant medical comorbidities
- Contraindicated for general anesthesia or surgery.
- Known bleeding or clotting disorder.
- Pregnant or suspected to be pregnant or is lactating.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Nipple Sparing Mastectomy
|
Nipple-sparing mastectomy using da Vinci Surgical Systems.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary Safety: Incidence of adverse events
Time Frame: Assessed during surgery to 42 days after surgery
|
Incidence of intraoperative and post-operative procedure and device-related adverse events
|
Assessed during surgery to 42 days after surgery
|
Primary Effectiveness: No conversions to open NSM
Time Frame: Assessed during surgery
|
Conversion is defined as conversion of da Vinci robotic-assisted surgery to open surgery
|
Assessed during surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of breast cancer
Time Frame: Annual through 5 year post-operatively
|
Occurrence and recurrence of breast cancer
|
Annual through 5 year post-operatively
|
Patient reported outcomes
Time Frame: Pre-operatively, post-operatively at 42 days, annually through 5 years
|
BREAST-Q
|
Pre-operatively, post-operatively at 42 days, annually through 5 years
|
Long-term safety: incidence of adverse events
Time Frame: Annually through 5 years post-operatively
|
Incidence of breast procedure-related adverse events during long-term follow up
|
Annually through 5 years post-operatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ISI dV Xi-NSM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nipple Sparing Mastectomy
-
Intuitive SurgicalRecruiting
-
Intuitive SurgicalTerminatedProphylactic Nipple Sparing Mastectomy (NSM)Italy, France
-
Stanford UniversityNot yet recruitingMastectomy | Nipple Sparing Mastectomy | Prophylactic Mastectomy | Gender Affirmation Surgery | Benign Breast ConditionUnited States
-
Georgetown UniversityUnknownBreast Cancer | Mastectomy; Lymphedema | Nipple-sparing Mastectomy | Same Day Surgery | Skin-sparing MastectomyUnited States
-
Gangnam Severance HospitalCompletedBreast Cancer | Nipple Sparing MastectomyKorea, Republic of
-
Chang Gung Memorial HospitalIntuitive SurgicalActive, not recruitingBreast Cancer | BRCA1 Mutation | BRCA2 Mutation | Nipple-sparing Mastectomy | Prophylactic MastectomyTaiwan
-
Mayo ClinicWithdrawnInverted Nipple | Retracted NippleUnited States
-
University of British ColumbiaCompleted
-
University of Nove de JulhoUnknown
-
American University of Beirut Medical CenterCompletedBreastfeeding | Inverted NippleLebanon
Clinical Trials on Nipple-Sparing Mastectomy
-
Severance HospitalSamsung Medical Center; Asan Medical Center; Kyungpook National University Chilgok...RecruitingBreast Neoplasms | Benign Breast Disease | Germline BRCA1 Gene Mutation | Germline BRCA2 Gene Mutation | Germline Mutation AbnormalityKorea, Republic of
-
Changhua Christian HospitalMinistry of Science and Technology, Taiwan; Intuitive SurgicalRecruiting
-
Severance HospitalSamsung Medical Center; Changhua Christian Hospital; European Institute of OncologyCompletedRecurrence | Postoperative Complications | Breast Cancer | Breast Neoplasms | Surgery | Surgery--Complications | BRCA1 Mutation | BRCA2 MutationKorea, Republic of
-
Yonsei UniversityRecruitingBreast Cancer Patients in Stage 0-3A in Preoperative EvaluationKorea, Republic of
-
Changhua Christian HospitalMinistry of Science and Technology, Taiwan; Intuitive SurgicalUnknownBreast Cancer FemaleTaiwan, Korea, Republic of, Italy
-
Intuitive SurgicalRecruiting
-
Wake Forest University Health SciencesCompletedBreast Cancer | Breast Reconstruction | CosmesisUnited States
-
Institut Claudius RegaudInstitut Paoli-CalmettesActive, not recruiting
-
Alexandria UniversityCompleted
-
Intuitive SurgicalTerminatedProphylactic Nipple Sparing Mastectomy (NSM)Italy, France